# Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

> **NCT00709969** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 310 (actual)

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **DRUG:** Artemether-lumefantrine

## Key facts

- **NCT ID:** NCT00709969
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2003-02
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2008-07-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00709969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00709969, "Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00709969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*